Literature DB >> 11897427

The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation.

Kristina Ståhl1, Malin Claesson, Pontus Lilliehorn, Helena Lindén, Kjell Bäckström.   

Abstract

The aim of this study was to investigate the effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation. A 2(4) full factorial experimentally designed study was performed to investigate the influence of the following independent spray drying variables: feed flow rate, nozzle gas flow rate, inlet air temperature and aspirator capacity (drying gas flow rate). Human insulin (biosynthetic and Ph.Eur. quality) was dissolved in distilled water to concentrations of 5 mg/ml. The solutions were spray dried in a Mini Spray Dryer Büchi and the dry powders produced were characterized by high performance liquid chromatography, size exclusion chromatography, laser diffraction, thermo gravimetric analysis, scanning electron microscopy and weighing. The degradation of insulin was found to be affected mainly by the process variables that determine the outlet air temperature, i.e.: inlet air temperature, aspirator capacity and feed flow rate. The outlet air temperature should be kept below 120 degrees C to avoid degradation. A statistical optimization of the spray drying variables was performed, and found to recommend an experiment with an outlet air temperature of 61+/-4 degrees C. This experiment ought to generate a yield of 54+/-7% by weight of particles with a mass median diameter 2.9+/-0.4 microm, moisture content 3.9+/-0.5% by weight, content of high molecular weight proteins 0.3+/-0.1% by area, A-21 desamido insulin 0.3+/-0.05% by area and other insulin related compounds 0.3+/-0.1% by area.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897427     DOI: 10.1016/s0378-5173(01)00945-0

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  24 in total

1.  Analysis of process parameters affecting spray-dried oily core nanocapsules using factorial design.

Authors:  Tao Zhang; Bi-Botti C Youan
Journal:  AAPS PharmSciTech       Date:  2010-09-15       Impact factor: 3.246

2.  Nano-coating of beta-galactosidase onto the surface of lactose by using an ultrasound-assisted technique.

Authors:  Natalja Genina; Heikki Räikkönen; Jyrki Heinämäki; Peep Veski; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2010-05-29       Impact factor: 3.246

Review 3.  Particle engineering for pulmonary drug delivery.

Authors:  Albert H L Chow; Henry H Y Tong; Pratibhash Chattopadhyay; Boris Y Shekunov
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 4.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

5.  Design of experiments-based monitoring of critical quality attributes for the spray-drying process of insulin by NIR spectroscopy.

Authors:  Morten Jonas Maltesen; Marco van de Weert; Holger Grohganz
Journal:  AAPS PharmSciTech       Date:  2012-05-15       Impact factor: 3.246

Review 6.  Spray drying as an advantageous strategy for enhancing pharmaceuticals bioavailability.

Authors:  Alaa Hamed Salama
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

7.  Dry powder aerosols to co-deliver antibiotics and nutrient dispersion compounds for enhanced bacterial biofilm eradication.

Authors:  S Sommerfeld Ross; S Gharse; L Sanchez; J Fiegel
Journal:  Int J Pharm       Date:  2017-08-04       Impact factor: 5.875

8.  A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery.

Authors:  S Focaroli; P T Mah; J E Hastedt; I Gitlin; S Oscarson; J V Fahy; A M Healy
Journal:  Int J Pharm       Date:  2019-03-05       Impact factor: 5.875

9.  Homogeneous nanoparticles to enhance the efficiency of a hydrophobic drug, antihyperlipidemic probucol, characterized by solid-state NMR.

Authors:  Takeshi Io; Toshiro Fukami; Kazutoshi Yamamoto; Toyofumi Suzuki; Jiadi Xu; Kazuo Tomono; Ayyalusamy Ramamoorthy
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

Review 10.  Nanomedicine in pulmonary delivery.

Authors:  Heidi M Mansour; Yun-Seok Rhee; Xiao Wu
Journal:  Int J Nanomedicine       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.